IBDEI0BH.m

IBDEI0BH ; ; 01-AUG-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022

 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.4,979,0)

 ;;=INFECTIOUS DISEASE^10^74

 ;;^UTILITY(U,$J,358.4,980,0)

 ;;=INTERSTITIAL LUNG DISEASE^11^74

 ;;^UTILITY(U,$J,358.4,981,0)

 ;;=MUSCULOSKELETAL^12^74

 ;;^UTILITY(U,$J,358.4,982,0)

 ;;=SUTURES^24^74

 ;;^UTILITY(U,$J,358.4,983,0)

 ;;=RADIATION^20^74

 ;;^UTILITY(U,$J,358.4,984,0)

 ;;=OCCUPATIONAL^16^74

 ;;^UTILITY(U,$J,358.4,985,0)

 ;;=PAIN^17^74

 ;;^UTILITY(U,$J,358.4,986,0)

 ;;=PLEURAL DISEASE^18^74

 ;;^UTILITY(U,$J,358.4,987,0)

 ;;=PSYCHIATRIC/BEHAVIORAL^19^74

 ;;^UTILITY(U,$J,358.4,988,0)

 ;;=SKIN^21^74

 ;;^UTILITY(U,$J,358.4,989,0)

 ;;=NEUROLOGIC^13^74

 ;;^UTILITY(U,$J,358.4,990,0)

 ;;=OBSTRUCTIVE DISEASE^14^74

 ;;^UTILITY(U,$J,358.4,991,0)

 ;;=VASCULAR^26^74

 ;;^UTILITY(U,$J,358.4,992,0)

 ;;=SYMPTOMS^25^74

 ;;^UTILITY(U,$J,358.4,993,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74

 ;;^UTILITY(U,$J,358.4,994,0)

 ;;=VACCINATIONS^12^75

 ;;^UTILITY(U,$J,358.4,995,0)

 ;;=INJECTION^5^75

 ;;^UTILITY(U,$J,358.4,996,0)

 ;;=EDUCATION/TRAINING^3^75

 ;;^UTILITY(U,$J,358.4,997,0)

 ;;=COUNSELING^2^75

 ;;^UTILITY(U,$J,358.4,998,0)

 ;;=EVALUATIONS^4^75

 ;;^UTILITY(U,$J,358.4,999,0)

 ;;=SPINAL INJECTION CODES^8^75

 ;;^UTILITY(U,$J,358.4,1000,0)

 ;;=SUPPLIES^9^75

 ;;^UTILITY(U,$J,358.4,1001,0)

 ;;=TREATMENT PROCEDURES^10^75

 ;;^UTILITY(U,$J,358.4,1002,0)

 ;;=TRIGGER POINT INJECTIONS^11^75

 ;;^UTILITY(U,$J,358.4,1003,0)

 ;;=ACUPUNCTURE^1^75

 ;;^UTILITY(U,$J,358.4,1004,0)

 ;;=NAILS^7^75

 ;;^UTILITY(U,$J,358.4,1005,0)

 ;;=INTRATHECAL BACLOFED PUMP REFILL/ADJ^6^75

 ;;^UTILITY(U,$J,358.4,1006,0)

 ;;=NEW PT-OFFICE^2^76

 ;;^UTILITY(U,$J,358.4,1007,0)

 ;;=ESTABLISHED PT-OFFICE^1^76

 ;;^UTILITY(U,$J,358.4,1008,0)

 ;;=CONSULTATIONS^3^76

 ;;^UTILITY(U,$J,358.4,1009,0)

 ;;=HOME VISIT-EST PT^4^76

 ;;^UTILITY(U,$J,358.4,1010,0)

 ;;=HOME VISIT-NEW PT^5^76

 ;;^UTILITY(U,$J,358.4,1011,0)

 ;;=CARDIOVASCULAR^2^77

 ;;^UTILITY(U,$J,358.4,1012,0)

 ;;=EXTERNAL CAUSES (SECONDARY DX ONLY)^3^77

 ;;^UTILITY(U,$J,358.4,1013,0)

 ;;=MENTAL HEALTH^4^77

 ;;^UTILITY(U,$J,358.4,1014,0)

 ;;=MUSCULOSKELETAL^5^77

 ;;^UTILITY(U,$J,358.4,1015,0)

 ;;=NEPHRO/GU/GI^6^77

 ;;^UTILITY(U,$J,358.4,1016,0)

 ;;=PARAPLEGIA^8^77

 ;;^UTILITY(U,$J,358.4,1017,0)

 ;;=QUADRAPLEGIA^9^77

 ;;^UTILITY(U,$J,358.4,1018,0)

 ;;=ULCERS^13^77

 ;;^UTILITY(U,$J,358.4,1019,0)

 ;;=OTHER HEALTH STATUS FACTORS^7^77

 ;;^UTILITY(U,$J,358.4,1020,0)

 ;;=COMMON DIAGNOSES^1^77

 ;;^UTILITY(U,$J,358.4,1021,0)

 ;;=SUICIDAL IDEATIONS/ATTEMPTS^12^77

 ;;^UTILITY(U,$J,358.4,1022,0)

 ;;=SPORT PARTICIPATION^11^77

 ;;^UTILITY(U,$J,358.4,1023,0)

 ;;=SPASM OF MUSCLE (SPASTICITY)^10^77

 ;;^UTILITY(U,$J,358.4,1024,0)

 ;;=MD/NP/PA ^1^78

 ;;^UTILITY(U,$J,358.4,1025,0)

 ;;=RN/LPN/SW/OTH HC PROF^2^78

 ;;^UTILITY(U,$J,358.4,1026,0)

 ;;=COMMON DIAGNOSES^1^79

 ;;^UTILITY(U,$J,358.4,1027,0)

 ;;=BODY MASS INDEX^3^79

 ;;^UTILITY(U,$J,358.4,1028,0)

 ;;=OBESITY^5^79

 ;;^UTILITY(U,$J,358.4,1029,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^6^79

 ;;^UTILITY(U,$J,358.4,1030,0)

 ;;=ANTICOAGULATION^2^79

 ;;^UTILITY(U,$J,358.4,1031,0)

 ;;=EYE^4^79

 ;;^UTILITY(U,$J,358.4,1032,0)

 ;;=TELE-EYE PROCEDURES^1^80

 ;;^UTILITY(U,$J,358.4,1033,0)

 ;;=LOW VISION / BLINDNESS^21^81

 ;;^UTILITY(U,$J,358.4,1034,0)

 ;;=RETINA - VASCULAR^12^81

 ;;^UTILITY(U,$J,358.4,1035,0)

 ;;=EYELIDS / LASHES^2^81

 ;;^UTILITY(U,$J,358.4,1036,0)

 ;;=NEURO / STRABISMUS^18^81

 ;;^UTILITY(U,$J,358.4,1037,0)

 ;;=ORBIT - PLASTICS^20^81

 ;;^UTILITY(U,$J,358.4,1038,0)

 ;;=VITREOUS^17^81

 ;;^UTILITY(U,$J,358.4,1039,0)

 ;;=ORBIT - TRAUMA^19^81

 ;;^UTILITY(U,$J,358.4,1040,0)

 ;;=LACRIMAL / NLD / NEOPLASMS^3^81

 ;;^UTILITY(U,$J,358.4,1041,0)

 ;;=MOST FREQUENT^1^81

 ;;^UTILITY(U,$J,358.4,1042,0)

 ;;=CONJUNCTIVA / SCLERA^4^81

 ;;^UTILITY(U,$J,358.4,1043,0)

 ;;=CORNEA / ULCER^5^81

 ;;^UTILITY(U,$J,358.4,1044,0)

 ;;=LENS / CATARACT / POSTOP^6^81

 ;;^UTILITY(U,$J,358.4,1045,0)

 ;;=IRIS / UVEITIS^7^81

 ;;^UTILITY(U,$J,358.4,1046,0)

 ;;=GLAUCOMA - OPEN ANGLE^8^81

 ;;^UTILITY(U,$J,358.4,1047,0)

 ;;=GLAUCOMA - CLOSED ANGLE^9^81

 ;;^UTILITY(U,$J,358.4,1048,0)

 ;;=GLAUCOMA - SECONDARY^10^81

 ;;^UTILITY(U,$J,358.4,1049,0)

 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^81

 ;;^UTILITY(U,$J,358.4,1050,0)

 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^81

 ;;^UTILITY(U,$J,358.4,1051,0)

 ;;=RETINA - MACULA^11^81

 ;;^UTILITY(U,$J,358.4,1052,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^81

 ;;^UTILITY(U,$J,358.4,1053,0)

 ;;=PMH / OTHER^22^81

 ;;^UTILITY(U,$J,358.4,1054,0)

 ;;=RETINA - VEGF INJECT DX CODES^16^81

 ;;^UTILITY(U,$J,358.4,1055,0)

 ;;=RETINA - DIABETIC RETINOPATHY^13^81

 ;;^UTILITY(U,$J,358.4,1056,0)

 ;;=COVID-19 & RELATED^24^81

 ;;^UTILITY(U,$J,358.4,1057,0)

 ;;=PRE-OP VISIT^1^82

 ;;^UTILITY(U,$J,358.4,1058,0)

 ;;=CONSULTATION-CLINICIAN^2^82

 ;;^UTILITY(U,$J,358.4,1059,0)

 ;;=POST-OP VISIT^4^82

 ;;^UTILITY(U,$J,358.4,1060,0)

 ;;=NEW PATIENT^3^82

 ;;^UTILITY(U,$J,358.4,1061,0)

 ;;=A DIAGNOSIS^1^83

 ;;^UTILITY(U,$J,358.4,1062,0)

 ;;=B DIAGNOSIS^2^83

 ;;^UTILITY(U,$J,358.4,1063,0)

 ;;=C DIAGNOSIS^3^83

 ;;^UTILITY(U,$J,358.4,1064,0)

 ;;=CANCER (NOT MELANOMA)^4^83

 ;;^UTILITY(U,$J,358.4,1065,0)

 ;;=D DIAGNOSIS^5^83

 ;;^UTILITY(U,$J,358.4,1066,0)

 ;;=E/F DIAGNOSIS^6^83

 ;;^UTILITY(U,$J,358.4,1067,0)

 ;;=G DIAGNOSIS^7^83

 ;;^UTILITY(U,$J,358.4,1068,0)

 ;;=H DIAGNOSIS^8^83

 ;;^UTILITY(U,$J,358.4,1069,0)

 ;;=I DIAGNOSIS^9^83

 ;;^UTILITY(U,$J,358.4,1070,0)

 ;;=J/K/L DIAGNOSIS^10^83

 ;;^UTILITY(U,$J,358.4,1071,0)

 ;;=M DIAGNOSIS^11^83

 ;;^UTILITY(U,$J,358.4,1072,0)

 ;;=N/O DIAGNOSIS^12^83

 ;;^UTILITY(U,$J,358.4,1073,0)

 ;;=P DIAGNOSIS^13^83

 ;;^UTILITY(U,$J,358.4,1074,0)

 ;;=R DIAGNOSIS^15^83

 ;;^UTILITY(U,$J,358.4,1075,0)

 ;;=S DIAGNOSIS^16^83

 ;;^UTILITY(U,$J,358.4,1076,0)

 ;;=T/U DIAGNOSIS^18^83

 ;;^UTILITY(U,$J,358.4,1077,0)

 ;;=V/W/X/Y/Z DIAGNOSIS^18^83

 ;;^UTILITY(U,$J,358.4,1078,0)

 ;;=PRE-OP,POST-OP,COUNSELING^14^83

 ;;^UTILITY(U,$J,358.4,1079,0)

 ;;=SUICIDE IDEATION/ATTEMPT^17^83

 ;;^UTILITY(U,$J,358.4,1080,0)

 ;;=NERVE BLOCK^13^84

 ;;^UTILITY(U,$J,358.4,1081,0)

 ;;=CATH^2^84

 ;;^UTILITY(U,$J,358.4,1082,0)

 ;;=CVA DEVICE^4^84

 ;;^UTILITY(U,$J,358.4,1083,0)

 ;;=EPIDURAL^5^84

 ;;^UTILITY(U,$J,358.4,1084,0)

 ;;=FOREARM/WRIST/HAND^6^84

 ;;^UTILITY(U,$J,358.4,1085,0)

 ;;=HEAD^6^84

 ;;^UTILITY(U,$J,358.4,1086,0)

 ;;=INTRATHORACIC^8^84

 ;;^UTILITY(U,$J,358.4,1087,0)

 ;;=IV^9^84

 ;;^UTILITY(U,$J,358.4,1088,0)

 ;;=LOWER ABDOMEN^10^84

 ;;^UTILITY(U,$J,358.4,1089,0)

 ;;=LOWER LEG^11^84

 ;;^UTILITY(U,$J,358.4,1090,0)

 ;;=NECK^12^84

 ;;^UTILITY(U,$J,358.4,1091,0)

 ;;=ARTERIAL^1^84

 ;;^UTILITY(U,$J,358.4,1092,0)

 ;;=OTHER^14^84

 ;;^UTILITY(U,$J,358.4,1093,0)

 ;;=PELVIS^15^84

 ;;^UTILITY(U,$J,358.4,1094,0)

 ;;=RADIOLOGICAL PROCEDURE^17^84

 ;;^UTILITY(U,$J,358.4,1095,0)

 ;;=SHOULDER/AXILLA^18^84

 ;;^UTILITY(U,$J,358.4,1096,0)

 ;;=SPINAL NERVES^19^84

 ;;^UTILITY(U,$J,358.4,1097,0)

 ;;=SPINE/SPINAL CORD^20^84

 ;;^UTILITY(U,$J,358.4,1098,0)

 ;;=TEE^22^84

 ;;^UTILITY(U,$J,358.4,1099,0)

 ;;=THORAX^23^84

 ;;^UTILITY(U,$J,358.4,1100,0)

 ;;=UPPER ABDOMEN^24^84

 ;;^UTILITY(U,$J,358.4,1101,0)

 ;;=UPPER ARM/ELBOW^25^84

 ;;^UTILITY(U,$J,358.4,1102,0)

 ;;=UPPER LEG^26^84

 ;;^UTILITY(U,$J,358.4,1103,0)

 ;;=CRITICAL CARE^3^84

 ;;^UTILITY(U,$J,358.4,1104,0)

 ;;=INJECT-SPINE^7^84

 ;;^UTILITY(U,$J,358.4,1105,0)

 ;;=QUALIFYING CIRCUMSTANCES^16^84

 ;;^UTILITY(U,$J,358.4,1106,0)

 ;;=TEAM CONFERENCE^21^84

 ;;^UTILITY(U,$J,358.4,1107,0)

 ;;=VAGINA^27^84

 ;;^UTILITY(U,$J,358.4,1108,0)

 ;;=HOSPICE CARE SUPERVISION^2^85

 ;;^UTILITY(U,$J,358.4,1109,0)

 ;;=PROLONGED SERVICES^3^85

 ;;^UTILITY(U,$J,358.4,1110,0)

 ;;=ADVANCE CARE PLANNING^1^85

 ;;^UTILITY(U,$J,358.4,1111,0)

 ;;=TEAM CONFERENCE^4^85

 ;;^UTILITY(U,$J,358.4,1112,0)

 ;;=NEOPLASMS^9^86

 ;;^UTILITY(U,$J,358.4,1113,0)

 ;;=CARDIOVASCULAR DISORDERS^2^86

 ;;^UTILITY(U,$J,358.4,1114,0)

 ;;=MENTAL HEALTH^8^86

 ;;^UTILITY(U,$J,358.4,1115,0)

 ;;=NEUROLOGICAL CONDITIONS^10^86

 ;;^UTILITY(U,$J,358.4,1116,0)

 ;;=GI DISORDERS^5^86

 ;;^UTILITY(U,$J,358.4,1117,0)

 ;;=LIVER DISORDERS^7^86

 ;;^UTILITY(U,$J,358.4,1118,0)

 ;;=KIDNEY DISORDERS^6^86

 ;;^UTILITY(U,$J,358.4,1119,0)

 ;;=RESPIRATORY DISORDERS^11^86

 ;;^UTILITY(U,$J,358.4,1120,0)

 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^86

 ;;^UTILITY(U,$J,358.4,1121,0)

 ;;=OTHER CONDITIONS^13^86

 ;;^UTILITY(U,$J,358.4,1122,0)

 ;;=DEMENTIA^3^86

 ;;^UTILITY(U,$J,358.4,1123,0)

 ;;=GENERAL IM^4^86

 ;;^UTILITY(U,$J,358.4,1124,0)

 ;;=OTHER BACTERIAL DISEASES^12^86

 ;;^UTILITY(U,$J,358.4,1125,0)

 ;;=INPATIENT CONSULTATIONS^1^87

 ;;^UTILITY(U,$J,358.4,1126,0)

 ;;=INITIAL INPATIENT CARE^2^87

 ;;^UTILITY(U,$J,358.4,1127,0)

 ;;=SUBSEQUENT INPATIENT CARE^3^87

 ;;^UTILITY(U,$J,358.4,1128,0)

 ;;=DISCHARGE/PRONOUNCEMENT^4^87

 ;;^UTILITY(U,$J,358.4,1129,0)

 ;;=NH INITIAL INPATIENT CARE^5^87

 ;;^UTILITY(U,$J,358.4,1130,0)

 ;;=NH SUBSEQUENT INPATIENT CARE^6^87

 ;;^UTILITY(U,$J,358.4,1131,0)

 ;;=NH DISCHARGE/PRONOUNCEMENT^7^87

 ;;^UTILITY(U,$J,358.4,1132,0)

 ;;=HOSPICE CARE SUPERVISION^4^88

 ;;^UTILITY(U,$J,358.4,1133,0)

 ;;=ADVANCE LIFE PLANNING^2^88

 ;;^UTILITY(U,$J,358.4,1134,0)

 ;;=EDUCATION^3^88

 ;;^UTILITY(U,$J,358.4,1135,0)

 ;;=NON-VIDEO MONITORING^5^88

 ;;^UTILITY(U,$J,358.4,1136,0)

 ;;=TEAM CONFERENCE^7^88

 ;;^UTILITY(U,$J,358.4,1137,0)

 ;;=PROLONGED SERVICES^6^88

 ;;^UTILITY(U,$J,358.4,1138,0)

 ;;=ADVANCE CARE PLANNING^1^88

 ;;^UTILITY(U,$J,358.4,1139,0)

 ;;=NEW PATIENT ^2^89

 ;;^UTILITY(U,$J,358.4,1140,0)

 ;;=ESTABLISHED PATIENT ^1^89

 ;;^UTILITY(U,$J,358.4,1141,0)

 ;;=CONSULTATIONS ^3^89

 ;;^UTILITY(U,$J,358.4,1142,0)

 ;;=NEOPLASMS^9^90

 ;;^UTILITY(U,$J,358.4,1143,0)

 ;;=CARDIOVASCULAR DISORDERS^2^90

 ;;^UTILITY(U,$J,358.4,1144,0)

 ;;=MENTAL HEALTH^8^90

 ;;^UTILITY(U,$J,358.4,1145,0)

 ;;=NEUROLOGICAL CONDITIONS^10^90

 ;;^UTILITY(U,$J,358.4,1146,0)

 ;;=GI DISORDERS^5^90

 ;;^UTILITY(U,$J,358.4,1147,0)

 ;;=LIVER DISORDERS^7^90

 ;;^UTILITY(U,$J,358.4,1148,0)

 ;;=KIDNEY DISORDERS^6^90

 ;;^UTILITY(U,$J,358.4,1149,0)

 ;;=RESPIRATORY DISORDERS^11^90

 ;;^UTILITY(U,$J,358.4,1150,0)

 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^90

 ;;^UTILITY(U,$J,358.4,1151,0)

 ;;=OTHER CONDITIONS^13^90

 ;;^UTILITY(U,$J,358.4,1152,0)

 ;;=DEMENTIA^3^90

 ;;^UTILITY(U,$J,358.4,1153,0)

 ;;=GENERAL IM^4^90

 ;;^UTILITY(U,$J,358.4,1154,0)

 ;;=OTHER BACTERIAL DISEASES^12^90

 ;;^UTILITY(U,$J,358.4,1155,0)

 ;;=COVID-19 CONFIRMED^2^91

 ;;^UTILITY(U,$J,358.4,1156,0)

 ;;=COVID-19 EXPOSURE^3^91

 ;;^UTILITY(U,$J,358.4,1157,0)

 ;;=COVID-19 RELATED COND/SYMP^5^91

 ;;^UTILITY(U,$J,358.4,1158,0)

 ;;=COVID-19 SCREEN^1^91

 ;;^UTILITY(U,$J,358.4,1159,0)

 ;;=COVID-19 PRE-OP^4^91

 ;;^UTILITY(U,$J,358.4,1160,0)

 ;;=COVID-19 VACCINE STATUS^6^91

 ;;^UTILITY(U,$J,358.4,1161,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^91

 ;;^UTILITY(U,$J,358.4,1162,0)

 ;;=COVID-19 ^1^92

 ;;^UTILITY(U,$J,358.4,1163,0)

 ;;=COVID-19 CONFIRMED^2^93

 ;;^UTILITY(U,$J,358.4,1164,0)

 ;;=COVID-19 EXPOSURE^3^93

 ;;^UTILITY(U,$J,358.4,1165,0)

 ;;=COVID-19 RELATED COND/SYMP^5^93

 ;;^UTILITY(U,$J,358.4,1166,0)

 ;;=COVID-19 SCREEN^1^93

 ;;^UTILITY(U,$J,358.4,1167,0)

 ;;=COVID-19 PRE-OP^4^93

 ;;^UTILITY(U,$J,358.4,1168,0)

 ;;=COVID-19 VACCINE STATUS^6^93

 ;;^UTILITY(U,$J,358.4,1169,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^93

 ;;^UTILITY(U,$J,358.4,1178,0)

 ;;=REMOTE MONITORING^1^96

 ;;^UTILITY(U,$J,358.4,1179,0)

 ;;=ONLINE DIGITAL E/M-NONPROVIDER^3^96

 ;;^UTILITY(U,$J,358.4,1180,0)

 ;;=ONLINE DIGITAL E/M-PROVIDER^2^96

 ;;^UTILITY(U,$J,358.4,1181,0)

 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^97

 ;;^UTILITY(U,$J,358.4,1182,0)

 ;;=DIABETES MELLITUS^1^97

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI0BH   11943     printed  Feb 18, 2025@23:11:47                                                                                                                                                                                                   Page 2

IBDEI0BH  ; ; 01-AUG-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022

 +2        if 'DIFQR(358.4)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.4,979,0)

 +2       ;;=INFECTIOUS DISEASE^10^74

 +3       ;;^UTILITY(U,$J,358.4,980,0)

 +4       ;;=INTERSTITIAL LUNG DISEASE^11^74

 +5       ;;^UTILITY(U,$J,358.4,981,0)

 +6       ;;=MUSCULOSKELETAL^12^74

 +7       ;;^UTILITY(U,$J,358.4,982,0)

 +8       ;;=SUTURES^24^74

 +9       ;;^UTILITY(U,$J,358.4,983,0)

 +10      ;;=RADIATION^20^74

 +11      ;;^UTILITY(U,$J,358.4,984,0)

 +12      ;;=OCCUPATIONAL^16^74

 +13      ;;^UTILITY(U,$J,358.4,985,0)

 +14      ;;=PAIN^17^74

 +15      ;;^UTILITY(U,$J,358.4,986,0)

 +16      ;;=PLEURAL DISEASE^18^74

 +17      ;;^UTILITY(U,$J,358.4,987,0)

 +18      ;;=PSYCHIATRIC/BEHAVIORAL^19^74

 +19      ;;^UTILITY(U,$J,358.4,988,0)

 +20      ;;=SKIN^21^74

 +21      ;;^UTILITY(U,$J,358.4,989,0)

 +22      ;;=NEUROLOGIC^13^74

 +23      ;;^UTILITY(U,$J,358.4,990,0)

 +24      ;;=OBSTRUCTIVE DISEASE^14^74

 +25      ;;^UTILITY(U,$J,358.4,991,0)

 +26      ;;=VASCULAR^26^74

 +27      ;;^UTILITY(U,$J,358.4,992,0)

 +28      ;;=SYMPTOMS^25^74

 +29      ;;^UTILITY(U,$J,358.4,993,0)

 +30      ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74

 +31      ;;^UTILITY(U,$J,358.4,994,0)

 +32      ;;=VACCINATIONS^12^75

 +33      ;;^UTILITY(U,$J,358.4,995,0)

 +34      ;;=INJECTION^5^75

 +35      ;;^UTILITY(U,$J,358.4,996,0)

 +36      ;;=EDUCATION/TRAINING^3^75

 +37      ;;^UTILITY(U,$J,358.4,997,0)

 +38      ;;=COUNSELING^2^75

 +39      ;;^UTILITY(U,$J,358.4,998,0)

 +40      ;;=EVALUATIONS^4^75

 +41      ;;^UTILITY(U,$J,358.4,999,0)

 +42      ;;=SPINAL INJECTION CODES^8^75

 +43      ;;^UTILITY(U,$J,358.4,1000,0)

 +44      ;;=SUPPLIES^9^75

 +45      ;;^UTILITY(U,$J,358.4,1001,0)

 +46      ;;=TREATMENT PROCEDURES^10^75

 +47      ;;^UTILITY(U,$J,358.4,1002,0)

 +48      ;;=TRIGGER POINT INJECTIONS^11^75

 +49      ;;^UTILITY(U,$J,358.4,1003,0)

 +50      ;;=ACUPUNCTURE^1^75

 +51      ;;^UTILITY(U,$J,358.4,1004,0)

 +52      ;;=NAILS^7^75

 +53      ;;^UTILITY(U,$J,358.4,1005,0)

 +54      ;;=INTRATHECAL BACLOFED PUMP REFILL/ADJ^6^75

 +55      ;;^UTILITY(U,$J,358.4,1006,0)

 +56      ;;=NEW PT-OFFICE^2^76

 +57      ;;^UTILITY(U,$J,358.4,1007,0)

 +58      ;;=ESTABLISHED PT-OFFICE^1^76

 +59      ;;^UTILITY(U,$J,358.4,1008,0)

 +60      ;;=CONSULTATIONS^3^76

 +61      ;;^UTILITY(U,$J,358.4,1009,0)

 +62      ;;=HOME VISIT-EST PT^4^76

 +63      ;;^UTILITY(U,$J,358.4,1010,0)

 +64      ;;=HOME VISIT-NEW PT^5^76

 +65      ;;^UTILITY(U,$J,358.4,1011,0)

 +66      ;;=CARDIOVASCULAR^2^77

 +67      ;;^UTILITY(U,$J,358.4,1012,0)

 +68      ;;=EXTERNAL CAUSES (SECONDARY DX ONLY)^3^77

 +69      ;;^UTILITY(U,$J,358.4,1013,0)

 +70      ;;=MENTAL HEALTH^4^77

 +71      ;;^UTILITY(U,$J,358.4,1014,0)

 +72      ;;=MUSCULOSKELETAL^5^77

 +73      ;;^UTILITY(U,$J,358.4,1015,0)

 +74      ;;=NEPHRO/GU/GI^6^77

 +75      ;;^UTILITY(U,$J,358.4,1016,0)

 +76      ;;=PARAPLEGIA^8^77

 +77      ;;^UTILITY(U,$J,358.4,1017,0)

 +78      ;;=QUADRAPLEGIA^9^77

 +79      ;;^UTILITY(U,$J,358.4,1018,0)

 +80      ;;=ULCERS^13^77

 +81      ;;^UTILITY(U,$J,358.4,1019,0)

 +82      ;;=OTHER HEALTH STATUS FACTORS^7^77

 +83      ;;^UTILITY(U,$J,358.4,1020,0)

 +84      ;;=COMMON DIAGNOSES^1^77

 +85      ;;^UTILITY(U,$J,358.4,1021,0)

 +86      ;;=SUICIDAL IDEATIONS/ATTEMPTS^12^77

 +87      ;;^UTILITY(U,$J,358.4,1022,0)

 +88      ;;=SPORT PARTICIPATION^11^77

 +89      ;;^UTILITY(U,$J,358.4,1023,0)

 +90      ;;=SPASM OF MUSCLE (SPASTICITY)^10^77

 +91      ;;^UTILITY(U,$J,358.4,1024,0)

 +92      ;;=MD/NP/PA ^1^78

 +93      ;;^UTILITY(U,$J,358.4,1025,0)

 +94      ;;=RN/LPN/SW/OTH HC PROF^2^78

 +95      ;;^UTILITY(U,$J,358.4,1026,0)

 +96      ;;=COMMON DIAGNOSES^1^79

 +97      ;;^UTILITY(U,$J,358.4,1027,0)

 +98      ;;=BODY MASS INDEX^3^79

 +99      ;;^UTILITY(U,$J,358.4,1028,0)

 +100     ;;=OBESITY^5^79

 +101     ;;^UTILITY(U,$J,358.4,1029,0)

 +102     ;;=SUICIDE IDEATIONS/ATTEMPTS^6^79

 +103     ;;^UTILITY(U,$J,358.4,1030,0)

 +104     ;;=ANTICOAGULATION^2^79

 +105     ;;^UTILITY(U,$J,358.4,1031,0)

 +106     ;;=EYE^4^79

 +107     ;;^UTILITY(U,$J,358.4,1032,0)

 +108     ;;=TELE-EYE PROCEDURES^1^80

 +109     ;;^UTILITY(U,$J,358.4,1033,0)

 +110     ;;=LOW VISION / BLINDNESS^21^81

 +111     ;;^UTILITY(U,$J,358.4,1034,0)

 +112     ;;=RETINA - VASCULAR^12^81

 +113     ;;^UTILITY(U,$J,358.4,1035,0)

 +114     ;;=EYELIDS / LASHES^2^81

 +115     ;;^UTILITY(U,$J,358.4,1036,0)

 +116     ;;=NEURO / STRABISMUS^18^81

 +117     ;;^UTILITY(U,$J,358.4,1037,0)

 +118     ;;=ORBIT - PLASTICS^20^81

 +119     ;;^UTILITY(U,$J,358.4,1038,0)

 +120     ;;=VITREOUS^17^81

 +121     ;;^UTILITY(U,$J,358.4,1039,0)

 +122     ;;=ORBIT - TRAUMA^19^81

 +123     ;;^UTILITY(U,$J,358.4,1040,0)

 +124     ;;=LACRIMAL / NLD / NEOPLASMS^3^81

 +125     ;;^UTILITY(U,$J,358.4,1041,0)

 +126     ;;=MOST FREQUENT^1^81

 +127     ;;^UTILITY(U,$J,358.4,1042,0)

 +128     ;;=CONJUNCTIVA / SCLERA^4^81

 +129     ;;^UTILITY(U,$J,358.4,1043,0)

 +130     ;;=CORNEA / ULCER^5^81

 +131     ;;^UTILITY(U,$J,358.4,1044,0)

 +132     ;;=LENS / CATARACT / POSTOP^6^81

 +133     ;;^UTILITY(U,$J,358.4,1045,0)

 +134     ;;=IRIS / UVEITIS^7^81

 +135     ;;^UTILITY(U,$J,358.4,1046,0)

 +136     ;;=GLAUCOMA - OPEN ANGLE^8^81

 +137     ;;^UTILITY(U,$J,358.4,1047,0)

 +138     ;;=GLAUCOMA - CLOSED ANGLE^9^81

 +139     ;;^UTILITY(U,$J,358.4,1048,0)

 +140     ;;=GLAUCOMA - SECONDARY^10^81

 +141     ;;^UTILITY(U,$J,358.4,1049,0)

 +142     ;;=RETINA - CHOROID / TUMORS / INFLAM^14^81

 +143     ;;^UTILITY(U,$J,358.4,1050,0)

 +144     ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^81

 +145     ;;^UTILITY(U,$J,358.4,1051,0)

 +146     ;;=RETINA - MACULA^11^81

 +147     ;;^UTILITY(U,$J,358.4,1052,0)

 +148     ;;=SUICIDE IDEATIONS/ATTEMPTS^23^81

 +149     ;;^UTILITY(U,$J,358.4,1053,0)

 +150     ;;=PMH / OTHER^22^81

 +151     ;;^UTILITY(U,$J,358.4,1054,0)

 +152     ;;=RETINA - VEGF INJECT DX CODES^16^81

 +153     ;;^UTILITY(U,$J,358.4,1055,0)

 +154     ;;=RETINA - DIABETIC RETINOPATHY^13^81

 +155     ;;^UTILITY(U,$J,358.4,1056,0)

 +156     ;;=COVID-19 & RELATED^24^81

 +157     ;;^UTILITY(U,$J,358.4,1057,0)

 +158     ;;=PRE-OP VISIT^1^82

 +159     ;;^UTILITY(U,$J,358.4,1058,0)

 +160     ;;=CONSULTATION-CLINICIAN^2^82

 +161     ;;^UTILITY(U,$J,358.4,1059,0)

 +162     ;;=POST-OP VISIT^4^82

 +163     ;;^UTILITY(U,$J,358.4,1060,0)

 +164     ;;=NEW PATIENT^3^82

 +165     ;;^UTILITY(U,$J,358.4,1061,0)

 +166     ;;=A DIAGNOSIS^1^83

 +167     ;;^UTILITY(U,$J,358.4,1062,0)

 +168     ;;=B DIAGNOSIS^2^83

 +169     ;;^UTILITY(U,$J,358.4,1063,0)

 +170     ;;=C DIAGNOSIS^3^83

 +171     ;;^UTILITY(U,$J,358.4,1064,0)

 +172     ;;=CANCER (NOT MELANOMA)^4^83

 +173     ;;^UTILITY(U,$J,358.4,1065,0)

 +174     ;;=D DIAGNOSIS^5^83

 +175     ;;^UTILITY(U,$J,358.4,1066,0)

 +176     ;;=E/F DIAGNOSIS^6^83

 +177     ;;^UTILITY(U,$J,358.4,1067,0)

 +178     ;;=G DIAGNOSIS^7^83

 +179     ;;^UTILITY(U,$J,358.4,1068,0)

 +180     ;;=H DIAGNOSIS^8^83

 +181     ;;^UTILITY(U,$J,358.4,1069,0)

 +182     ;;=I DIAGNOSIS^9^83

 +183     ;;^UTILITY(U,$J,358.4,1070,0)

 +184     ;;=J/K/L DIAGNOSIS^10^83

 +185     ;;^UTILITY(U,$J,358.4,1071,0)

 +186     ;;=M DIAGNOSIS^11^83

 +187     ;;^UTILITY(U,$J,358.4,1072,0)

 +188     ;;=N/O DIAGNOSIS^12^83

 +189     ;;^UTILITY(U,$J,358.4,1073,0)

 +190     ;;=P DIAGNOSIS^13^83

 +191     ;;^UTILITY(U,$J,358.4,1074,0)

 +192     ;;=R DIAGNOSIS^15^83

 +193     ;;^UTILITY(U,$J,358.4,1075,0)

 +194     ;;=S DIAGNOSIS^16^83

 +195     ;;^UTILITY(U,$J,358.4,1076,0)

 +196     ;;=T/U DIAGNOSIS^18^83

 +197     ;;^UTILITY(U,$J,358.4,1077,0)

 +198     ;;=V/W/X/Y/Z DIAGNOSIS^18^83

 +199     ;;^UTILITY(U,$J,358.4,1078,0)

 +200     ;;=PRE-OP,POST-OP,COUNSELING^14^83

 +201     ;;^UTILITY(U,$J,358.4,1079,0)

 +202     ;;=SUICIDE IDEATION/ATTEMPT^17^83

 +203     ;;^UTILITY(U,$J,358.4,1080,0)

 +204     ;;=NERVE BLOCK^13^84

 +205     ;;^UTILITY(U,$J,358.4,1081,0)

 +206     ;;=CATH^2^84

 +207     ;;^UTILITY(U,$J,358.4,1082,0)

 +208     ;;=CVA DEVICE^4^84

 +209     ;;^UTILITY(U,$J,358.4,1083,0)

 +210     ;;=EPIDURAL^5^84

 +211     ;;^UTILITY(U,$J,358.4,1084,0)

 +212     ;;=FOREARM/WRIST/HAND^6^84

 +213     ;;^UTILITY(U,$J,358.4,1085,0)

 +214     ;;=HEAD^6^84

 +215     ;;^UTILITY(U,$J,358.4,1086,0)

 +216     ;;=INTRATHORACIC^8^84

 +217     ;;^UTILITY(U,$J,358.4,1087,0)

 +218     ;;=IV^9^84

 +219     ;;^UTILITY(U,$J,358.4,1088,0)

 +220     ;;=LOWER ABDOMEN^10^84

 +221     ;;^UTILITY(U,$J,358.4,1089,0)

 +222     ;;=LOWER LEG^11^84

 +223     ;;^UTILITY(U,$J,358.4,1090,0)

 +224     ;;=NECK^12^84

 +225     ;;^UTILITY(U,$J,358.4,1091,0)

 +226     ;;=ARTERIAL^1^84

 +227     ;;^UTILITY(U,$J,358.4,1092,0)

 +228     ;;=OTHER^14^84

 +229     ;;^UTILITY(U,$J,358.4,1093,0)

 +230     ;;=PELVIS^15^84

 +231     ;;^UTILITY(U,$J,358.4,1094,0)

 +232     ;;=RADIOLOGICAL PROCEDURE^17^84

 +233     ;;^UTILITY(U,$J,358.4,1095,0)

 +234     ;;=SHOULDER/AXILLA^18^84

 +235     ;;^UTILITY(U,$J,358.4,1096,0)

 +236     ;;=SPINAL NERVES^19^84

 +237     ;;^UTILITY(U,$J,358.4,1097,0)

 +238     ;;=SPINE/SPINAL CORD^20^84

 +239     ;;^UTILITY(U,$J,358.4,1098,0)

 +240     ;;=TEE^22^84

 +241     ;;^UTILITY(U,$J,358.4,1099,0)

 +242     ;;=THORAX^23^84

 +243     ;;^UTILITY(U,$J,358.4,1100,0)

 +244     ;;=UPPER ABDOMEN^24^84

 +245     ;;^UTILITY(U,$J,358.4,1101,0)

 +246     ;;=UPPER ARM/ELBOW^25^84

 +247     ;;^UTILITY(U,$J,358.4,1102,0)

 +248     ;;=UPPER LEG^26^84

 +249     ;;^UTILITY(U,$J,358.4,1103,0)

 +250     ;;=CRITICAL CARE^3^84

 +251     ;;^UTILITY(U,$J,358.4,1104,0)

 +252     ;;=INJECT-SPINE^7^84

 +253     ;;^UTILITY(U,$J,358.4,1105,0)

 +254     ;;=QUALIFYING CIRCUMSTANCES^16^84

 +255     ;;^UTILITY(U,$J,358.4,1106,0)

 +256     ;;=TEAM CONFERENCE^21^84

 +257     ;;^UTILITY(U,$J,358.4,1107,0)

 +258     ;;=VAGINA^27^84

 +259     ;;^UTILITY(U,$J,358.4,1108,0)

 +260     ;;=HOSPICE CARE SUPERVISION^2^85

 +261     ;;^UTILITY(U,$J,358.4,1109,0)

 +262     ;;=PROLONGED SERVICES^3^85

 +263     ;;^UTILITY(U,$J,358.4,1110,0)

 +264     ;;=ADVANCE CARE PLANNING^1^85

 +265     ;;^UTILITY(U,$J,358.4,1111,0)

 +266     ;;=TEAM CONFERENCE^4^85

 +267     ;;^UTILITY(U,$J,358.4,1112,0)

 +268     ;;=NEOPLASMS^9^86

 +269     ;;^UTILITY(U,$J,358.4,1113,0)

 +270     ;;=CARDIOVASCULAR DISORDERS^2^86

 +271     ;;^UTILITY(U,$J,358.4,1114,0)

 +272     ;;=MENTAL HEALTH^8^86

 +273     ;;^UTILITY(U,$J,358.4,1115,0)

 +274     ;;=NEUROLOGICAL CONDITIONS^10^86

 +275     ;;^UTILITY(U,$J,358.4,1116,0)

 +276     ;;=GI DISORDERS^5^86

 +277     ;;^UTILITY(U,$J,358.4,1117,0)

 +278     ;;=LIVER DISORDERS^7^86

 +279     ;;^UTILITY(U,$J,358.4,1118,0)

 +280     ;;=KIDNEY DISORDERS^6^86

 +281     ;;^UTILITY(U,$J,358.4,1119,0)

 +282     ;;=RESPIRATORY DISORDERS^11^86

 +283     ;;^UTILITY(U,$J,358.4,1120,0)

 +284     ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^86

 +285     ;;^UTILITY(U,$J,358.4,1121,0)

 +286     ;;=OTHER CONDITIONS^13^86

 +287     ;;^UTILITY(U,$J,358.4,1122,0)

 +288     ;;=DEMENTIA^3^86

 +289     ;;^UTILITY(U,$J,358.4,1123,0)

 +290     ;;=GENERAL IM^4^86

 +291     ;;^UTILITY(U,$J,358.4,1124,0)

 +292     ;;=OTHER BACTERIAL DISEASES^12^86

 +293     ;;^UTILITY(U,$J,358.4,1125,0)

 +294     ;;=INPATIENT CONSULTATIONS^1^87

 +295     ;;^UTILITY(U,$J,358.4,1126,0)

 +296     ;;=INITIAL INPATIENT CARE^2^87

 +297     ;;^UTILITY(U,$J,358.4,1127,0)

 +298     ;;=SUBSEQUENT INPATIENT CARE^3^87

 +299     ;;^UTILITY(U,$J,358.4,1128,0)

 +300     ;;=DISCHARGE/PRONOUNCEMENT^4^87

 +301     ;;^UTILITY(U,$J,358.4,1129,0)

 +302     ;;=NH INITIAL INPATIENT CARE^5^87

 +303     ;;^UTILITY(U,$J,358.4,1130,0)

 +304     ;;=NH SUBSEQUENT INPATIENT CARE^6^87

 +305     ;;^UTILITY(U,$J,358.4,1131,0)

 +306     ;;=NH DISCHARGE/PRONOUNCEMENT^7^87

 +307     ;;^UTILITY(U,$J,358.4,1132,0)

 +308     ;;=HOSPICE CARE SUPERVISION^4^88

 +309     ;;^UTILITY(U,$J,358.4,1133,0)

 +310     ;;=ADVANCE LIFE PLANNING^2^88

 +311     ;;^UTILITY(U,$J,358.4,1134,0)

 +312     ;;=EDUCATION^3^88

 +313     ;;^UTILITY(U,$J,358.4,1135,0)

 +314     ;;=NON-VIDEO MONITORING^5^88

 +315     ;;^UTILITY(U,$J,358.4,1136,0)

 +316     ;;=TEAM CONFERENCE^7^88

 +317     ;;^UTILITY(U,$J,358.4,1137,0)

 +318     ;;=PROLONGED SERVICES^6^88

 +319     ;;^UTILITY(U,$J,358.4,1138,0)

 +320     ;;=ADVANCE CARE PLANNING^1^88

 +321     ;;^UTILITY(U,$J,358.4,1139,0)

 +322     ;;=NEW PATIENT ^2^89

 +323     ;;^UTILITY(U,$J,358.4,1140,0)

 +324     ;;=ESTABLISHED PATIENT ^1^89

 +325     ;;^UTILITY(U,$J,358.4,1141,0)

 +326     ;;=CONSULTATIONS ^3^89

 +327     ;;^UTILITY(U,$J,358.4,1142,0)

 +328     ;;=NEOPLASMS^9^90

 +329     ;;^UTILITY(U,$J,358.4,1143,0)

 +330     ;;=CARDIOVASCULAR DISORDERS^2^90

 +331     ;;^UTILITY(U,$J,358.4,1144,0)

 +332     ;;=MENTAL HEALTH^8^90

 +333     ;;^UTILITY(U,$J,358.4,1145,0)

 +334     ;;=NEUROLOGICAL CONDITIONS^10^90

 +335     ;;^UTILITY(U,$J,358.4,1146,0)

 +336     ;;=GI DISORDERS^5^90

 +337     ;;^UTILITY(U,$J,358.4,1147,0)

 +338     ;;=LIVER DISORDERS^7^90

 +339     ;;^UTILITY(U,$J,358.4,1148,0)

 +340     ;;=KIDNEY DISORDERS^6^90

 +341     ;;^UTILITY(U,$J,358.4,1149,0)

 +342     ;;=RESPIRATORY DISORDERS^11^90

 +343     ;;^UTILITY(U,$J,358.4,1150,0)

 +344     ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^90

 +345     ;;^UTILITY(U,$J,358.4,1151,0)

 +346     ;;=OTHER CONDITIONS^13^90

 +347     ;;^UTILITY(U,$J,358.4,1152,0)

 +348     ;;=DEMENTIA^3^90

 +349     ;;^UTILITY(U,$J,358.4,1153,0)

 +350     ;;=GENERAL IM^4^90

 +351     ;;^UTILITY(U,$J,358.4,1154,0)

 +352     ;;=OTHER BACTERIAL DISEASES^12^90

 +353     ;;^UTILITY(U,$J,358.4,1155,0)

 +354     ;;=COVID-19 CONFIRMED^2^91

 +355     ;;^UTILITY(U,$J,358.4,1156,0)

 +356     ;;=COVID-19 EXPOSURE^3^91

 +357     ;;^UTILITY(U,$J,358.4,1157,0)

 +358     ;;=COVID-19 RELATED COND/SYMP^5^91

 +359     ;;^UTILITY(U,$J,358.4,1158,0)

 +360     ;;=COVID-19 SCREEN^1^91

 +361     ;;^UTILITY(U,$J,358.4,1159,0)

 +362     ;;=COVID-19 PRE-OP^4^91

 +363     ;;^UTILITY(U,$J,358.4,1160,0)

 +364     ;;=COVID-19 VACCINE STATUS^6^91

 +365     ;;^UTILITY(U,$J,358.4,1161,0)

 +366     ;;=SUICIDE IDEATIONS/ATTEMPTS^7^91

 +367     ;;^UTILITY(U,$J,358.4,1162,0)

 +368     ;;=COVID-19 ^1^92

 +369     ;;^UTILITY(U,$J,358.4,1163,0)

 +370     ;;=COVID-19 CONFIRMED^2^93

 +371     ;;^UTILITY(U,$J,358.4,1164,0)

 +372     ;;=COVID-19 EXPOSURE^3^93

 +373     ;;^UTILITY(U,$J,358.4,1165,0)

 +374     ;;=COVID-19 RELATED COND/SYMP^5^93

 +375     ;;^UTILITY(U,$J,358.4,1166,0)

 +376     ;;=COVID-19 SCREEN^1^93

 +377     ;;^UTILITY(U,$J,358.4,1167,0)

 +378     ;;=COVID-19 PRE-OP^4^93

 +379     ;;^UTILITY(U,$J,358.4,1168,0)

 +380     ;;=COVID-19 VACCINE STATUS^6^93

 +381     ;;^UTILITY(U,$J,358.4,1169,0)

 +382     ;;=SUICIDE IDEATIONS/ATTEMPTS^7^93

 +383     ;;^UTILITY(U,$J,358.4,1178,0)

 +384     ;;=REMOTE MONITORING^1^96

 +385     ;;^UTILITY(U,$J,358.4,1179,0)

 +386     ;;=ONLINE DIGITAL E/M-NONPROVIDER^3^96

 +387     ;;^UTILITY(U,$J,358.4,1180,0)

 +388     ;;=ONLINE DIGITAL E/M-PROVIDER^2^96

 +389     ;;^UTILITY(U,$J,358.4,1181,0)

 +390     ;;=SUICIDE IDEATIONS/ATTEMPTS^2^97

 +391     ;;^UTILITY(U,$J,358.4,1182,0)

 +392     ;;=DIABETES MELLITUS^1^97